Okairos

Okairos AG is a biopharmaceutical company focused on the discovery and development of genetic T-cell vaccines, including hepatitis C virus.

Business Model:

Revenue: $0

Employees: 1-10

Detailed Okairos Information

Okairos was acquired by GlaxoSmithKline.
The acquisition happend on 2013-05-29.
Details of the transaction were not public

Acquirer

Geographic Data

Okairos headquarters map

Address:

City: Basel

State: Basel-Stadt

Zip:

Country: Switzerland

Financial Info

Stage:

series b

Raised Last:

$21M

Raised Total:

$30M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Okairos AG, a bio-pharmaceutical company, focuses on the discovery and development of genetic T-cell vaccines, including hepatitis C virus. The company also provides health and allied services. It has operations in Rome and Naples, Italy. The company is based in Basel, Switzerland. Okairos AG was former subsidiary of Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research